NO20020913D0 - Androgenreseptor-modulatorforbindelser og fremgangsmåter - Google Patents

Androgenreseptor-modulatorforbindelser og fremgangsmåter

Info

Publication number: NO20020913D0
Authority: NO; Norway
Prior art keywords: methods; androgen receptor; receptor modulator; modulator compounds; compounds
Prior art date: 1999-08-27

Application number

NO20020913A

Other languages

English (en)

Other versions

NO20020913L (no

Inventor

Robert Higuchi

Kristen L Arienti

Mani Neelakandha

Barbara Pio

Lin Zhi

Penghui Chen

Thomas R Caferro

Original Assignee

Ligand Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-27

Filing date

2002-02-25

Publication date

2002-02-25

2002-02-25 Application filed by Ligand Pharm Inc filed Critical Ligand Pharm Inc

2002-02-25 Publication of NO20020913D0 publication Critical patent/NO20020913D0/no

2002-04-29 Publication of NO20020913L publication Critical patent/NO20020913L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Hematology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20020913A 1999-08-27 2002-02-25 Androgenreseptor-modulatorforbindelser og fremgangsmåter NO20020913L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15098899P	1999-08-27	1999-08-27
PCT/US2000/023520 WO2001016139A1 (en)	1999-08-27	2000-08-25	Androgen receptor modulator compounds and methods

Publications (2)

Publication Number	Publication Date
NO20020913D0 true NO20020913D0 (no)	2002-02-25
NO20020913L NO20020913L (no)	2002-04-29

Family

ID=22536855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20020913A NO20020913L (no)	1999-08-27	2002-02-25	Androgenreseptor-modulatorforbindelser og fremgangsmåter

Country Status (21)

Country	Link
US (3)	US6462038B1 (no)
EP (1)	EP1212330B1 (no)
JP (1)	JP2003508402A (no)
KR (1)	KR20020038741A (no)
CN (1)	CN1391576A (no)
AT (1)	ATE323709T1 (no)
AU (1)	AU778655B2 (no)
BG (1)	BG106550A (no)
BR (1)	BR0013597A (no)
CA (1)	CA2383077A1 (no)
CZ (1)	CZ2002711A3 (no)
DE (1)	DE60027443D1 (no)
HU (1)	HUP0202814A3 (no)
IL (1)	IL148045A0 (no)
MX (1)	MXPA02002032A (no)
NO (1)	NO20020913L (no)
PL (1)	PL353792A1 (no)
SK (1)	SK2732002A3 (no)
TR (1)	TR200200507T2 (no)
WO (1)	WO2001016139A1 (no)
ZA (1)	ZA200201056B (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6566372B1 (en)	1999-08-27	2003-05-20	Ligand Pharmaceuticals Incorporated	Bicyclic androgen and progesterone receptor modulator compounds and methods
CN1391576A (zh) *	1999-08-27	2003-01-15	利甘德药品公司	雄激素受体调节剂化合物及方法
US20040077605A1 (en)	2001-06-20	2004-04-22	Salvati Mark E.	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7001911B2 (en)	2000-06-28	2006-02-21	Bristol-Myers Squibb Company	Fused cyclic modulators of nuclear hormone receptor function
CA2413417A1 (en)	2000-06-28	2002-01-03	Bristol-Myers Squibb Company	Selective androgen receptor modulators and methods for their identification, design and use
US6953679B2 (en)	2000-09-19	2005-10-11	Bristol-Myers Squibb Company	Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
US7214690B2 (en) *	2001-02-23	2007-05-08	Ligand Pharmaceuticals Incorporated	Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
US7026484B2 (en)	2001-02-23	2006-04-11	Ligand Pharmaceuticals Incorporated	Tricyclic androgen receptor modulator compounds and methods
WO2003011824A1 (en)	2001-07-31	2003-02-13	Bristol-Myers Squibb Company	Bicyclic modulators of androgen receptor function
AU2002364082A1 (en)	2001-12-19	2003-07-09	Bristol-Myers Squibb Company	Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
WO2003090672A2 (en) *	2002-04-26	2003-11-06	Ortho-Mcneil Pharmaceutical, Inc.	2-(quinolonyl)-fused heterocycles as androgen receptor modulators
US7405234B2 (en)	2002-05-17	2008-07-29	Bristol-Myers Squibb Company	Bicyclic modulators of androgen receptor function
BR0312039A (pt) *	2002-06-25	2005-06-28	Wyeth Corp	Derivados ciclotiocarbamativos como moduladores de pr e uso destes para tratamento de distúrbios de pele
EP1567487A4 (en)	2002-11-15	2005-11-16	Bristol Myers Squibb Co	OPEN-CHAINED, PROLYL-FROSTED MODULATORS OF ANDROGEN RECEPTOR FUNCTION
MXPA05007605A (es)	2003-01-17	2005-09-30	Warner Lambert Co	Antagonista del receptor de androgenos.
EP1587509A2 (en)	2003-01-17	2005-10-26	Warner-Lambert Company LLC	Androgen receptor antagonists
MXPA05008464A (es)	2003-02-11	2005-10-18	Warner Lambert Co	Derivados de bencilurea y benciltiourea utiles como antagonistas del receptor de androgeno.
CA2515589A1 (en)	2003-02-11	2004-08-26	Warner-Lambert Company Llc	Urea and thiourea derivatives
US7009052B2 (en)	2003-03-20	2006-03-07	Warner Lambert Company Llc	Sulfonamide derivatives
US7098340B2 (en)	2003-05-14	2006-08-29	Warner Lambert Company Llc	Benzyl sulfonamide derivatives
JP2007500245A (ja) *	2003-06-10	2007-01-11	スミスクラインビーチャムコーポレーション	化合物
BRPI0413820A (pt)	2003-08-22	2006-10-24	Ligand Pharm Inc	derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
US7829552B2 (en)	2003-11-19	2010-11-09	Metabasis Therapeutics, Inc.	Phosphorus-containing thyromimetics
WO2005063494A1 (ja) *	2003-12-26	2005-07-14	Mitsubishi Chemical Corporation	光学記録媒体および色素
US7820702B2 (en)	2004-02-04	2010-10-26	Bristol-Myers Squibb Company	Sulfonylpyrrolidine modulators of androgen receptor function and method
US7625923B2 (en)	2004-03-04	2009-12-01	Bristol-Myers Squibb Company	Bicyclic modulators of androgen receptor function
US7696241B2 (en)	2004-03-04	2010-04-13	Bristol-Myers Squibb Company	Bicyclic compounds as modulators of androgen receptor function and method
US8519158B2 (en) *	2004-03-12	2013-08-27	Ligand Pharmaceuticals Incorporated	Androgen receptor modulator compounds and methods
WO2005111028A1 (en) *	2004-05-03	2005-11-24	Janssen Pharmaceutica N.V.	Novel indole derivatives as selective androgen receptor modulators (sarms)
CA2564953A1 (en) *	2004-05-03	2005-11-24	Janssen Pharmaceutica N.V.	Novel indole derivatives as selective androgen receptor modulators (sarms)
WO2006006065A1 (en) *	2004-07-08	2006-01-19	Warner-Lambert Company Llc	Androgen modulators
US7280723B2 (en) *	2005-05-06	2007-10-09	Schott Corporation	Illumination assembly including a rigid light-guiding element incorporating a numerical-aperture alteration taper
US8193357B2 (en)	2005-06-17	2012-06-05	Ligand Pharmaceuticals Incorporated	Androgen receptor modulator compounds
EP1928437A2 (en)	2005-08-26	2008-06-11	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
EP1916896A4 (en) *	2005-08-26	2010-08-11	Univ California	NOT STEROID-antiandrogens
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7790745B2 (en)	2005-10-21	2010-09-07	Bristol-Myers Squibb Company	Tetrahydroisoquinoline LXR Modulators
JP2009512711A (ja)	2005-10-21	2009-03-26	ブレインセルス，インコーポレイティド	Ｐｄｅ阻害による神経新生の調節
AU2006308889A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	GABA receptor mediated modulation of neurogenesis
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
EP2021000A2 (en)	2006-05-09	2009-02-11	Braincells, Inc.	Neurogenesis by modulating angiotensin
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
CN101663262B (zh)	2006-12-01	2014-03-26	百时美施贵宝公司	用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US8354446B2 (en)	2007-12-21	2013-01-15	Ligand Pharmaceuticals Incorporated	Selective androgen receptor modulators (SARMs) and uses thereof
EP2130831A1 (en)	2008-06-06	2009-12-09	InterMed Discovery GmbH	CDC25 inhibitors
WO2010093601A1 (en)	2009-02-10	2010-08-19	Metabasis Therapeutics, Inc.	Novel sulfonic acid-containing thyromimetics, and methods for their use
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
CN108659219B (zh) *	2018-06-08	2021-02-09	扬州大学	一种聚苯胺的制备方法
BR112021022008A2 (pt)	2019-05-14	2022-05-17	Nuvation Bio Inc	Compostos de direcionamento a receptor de hormônio nuclear anticâncer
WO2021097046A1 (en)	2019-11-13	2021-05-20	Nuvation Bio Inc.	Anti-cancer nuclear hormone receptor-targeting compounds
IL306010A (en)	2021-03-23	2023-11-01	Nuvation Bio Inc	Anticancer compounds against the nuclear hormone receptor
US12006314B2 (en)	2021-05-03	2024-06-11	Nuvation Bio Inc.	Anti-cancer nuclear hormone receptor-targeting compounds

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH590275A5 (no)	1970-03-16	1977-07-29	Hoffmann La Roche
US3979394A (en)	1970-12-11	1976-09-07	Agfa-Gevaert N.V.	Duplo quinoline compounds
GB1379387A (en)	1970-12-11	1975-01-02	Agfa Gevaert	Photoconductive recording materials
US3755332A (en)	1971-07-01	1973-08-28	Ciba Geigy Corp	Substituted 4 indazolaminoquinolines
GB1400993A (en)	1971-11-10	1975-07-16	Agfa Gevaert	Electrophotographic material
BE795696A (nl)	1972-02-28	1973-08-21	Agfa Gevaert Nv	Voor warmte gevoelige materialen
US3936461A (en) *	1973-09-24	1976-02-03	Warner-Lambert Company	Substituted 4-benzylquinolines
US3993656A (en)	1974-11-19	1976-11-23	Merck & Co., Inc.	1,8-Naphthyridine compounds
IE43079B1 (en)	1975-03-20	1980-12-17	Ici Ltd	Quinolone derivatives
US4138490A (en) *	1975-03-20	1979-02-06	Imperial Chemical Industries Limited	Analgesic compositions containing 1,2-dihydro-2-oxoquinol-4-ylpropionic acid derivatives
SU555119A1 (ru)	1975-05-19	1977-04-25	Предприятие П/Я Г-4913	Вулканизуема резинова смесь на основе полиизопренового каучука
LU77254A1 (no)	1977-05-04	1979-01-18
US4579134A (en) *	1977-09-08	1986-04-01	The Bridgeport Metal Goods Manufacturing Co.	Lipstick container
US4326055A (en)	1977-12-22	1982-04-20	Hoffmann-La Roche Inc.	Stilbene derivatives
JPS54154797A (en) *	1978-05-25	1979-12-06	Eisai Co Ltd	Benzimidazoquinolizine derivative and antibacterials comprising it
US4234589A (en)	1979-09-24	1980-11-18	E. R. Squibb & Sons, Inc.	Imidazolylethoxymethyl derivatives of 1,3-dioxolo quinolines
JPS5777676A (en)	1980-10-31	1982-05-15	Otsuka Pharmaceut Co Ltd	Carbostyril derivative
DE3202100A1 (de)	1982-01-23	1983-08-04	Basf Ag, 6700 Ludwigshafen	Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
US4534979A (en)	1982-06-28	1985-08-13	Usv Pharmaceutical Corp.	Polyene compounds useful in the treatment of psoriasis and allergic responses
US4427654A (en)	1982-07-27	1984-01-24	University Of Delaware	Wound healing compositions and formulations
US4505852A (en)	1982-11-29	1985-03-19	Enzyme Systems Products	7-Amino-4-trifluoromethylquinolone derived substrates and method for determining enzymes and inhibitors
US4539134A (en)	1982-12-02	1985-09-03	Halliburton Company	Methods and cleaning compositions for removing organic materials from metallic surfaces
JPS6056985A (ja) *	1983-09-08	1985-04-02	Sankyo Co Ltd	クマリン誘導体
PT79699B (en)	1983-12-22	1986-12-10	Pfizer	Process for preparing quinolone inotropic agents
NZ212209A (en)	1984-05-29	1988-08-30	Pfizer	Quinolone derivatives and pharmaceutical compositions
CH667868A5 (fr)	1984-09-05	1988-11-15	Oreal	Derives du benzonorbornene, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant.
DE3434944A1 (de)	1984-09-22	1986-04-03	Basf Ag, 6700 Ludwigshafen	L-substituierte tetralinderivate, ihre herstellung und verwendung
FR2580277B1 (fr)	1985-04-15	1988-06-10	Oreal	Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant
LU86022A1 (fr)	1985-07-25	1987-02-04	Cird	Derives aromatiques polycyliques,leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique
JPS62215581A (ja)	1986-03-18	1987-09-22	Koichi Shiyudo	フラボンカルボン酸誘導体
FR2601670B1 (fr)	1986-07-17	1988-10-07	Cird	Nouveaux derives bicycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
US5071773A (en)	1986-10-24	1991-12-10	The Salk Institute For Biological Studies	Hormone receptor-related bioassays
FR2605626B1 (fr)	1986-10-27	1989-06-02	Oreal	Nouveaux derives aromatiques bicycliques, leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire
US5081242A (en)	1986-12-22	1992-01-14	Ortho Pharmaceutical Corporation	6-benzoxazinyl- and 6-benzothiazinyl 2,3,4,5-tetrahydropyridazin-3-ones
GB8630702D0 (en)	1986-12-23	1987-02-04	Wellcome Found	Quinoline compound
FR2614618B1 (fr)	1987-04-30	1989-07-07	Cird	Derives heterocycliques polycycliques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire
EP0303418A3 (en)	1987-08-11	1990-11-07	Smithkline Beecham Laboratoires Pharmaceutiques	Substituted indolones, useful in the treatment of heart or asthmatic diseases
LU87040A1 (fr)	1987-11-04	1989-06-14	Oreal	Esters aromatiques polycycliques d'antibiotiques macrolidiques et lincosamidiques,leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant
US4981784A (en)	1987-12-02	1991-01-01	The Salk Institute For Biological Studies	Retinoic acid receptor method
WO1989007441A1 (en)	1988-02-10	1989-08-24	The Regents Of The University Of California	6-amino-1,2-benzopyrone antitumorigenic agents and method
DE3810706A1 (de)	1988-03-25	1989-10-05	Schering Ag	Substituierte cumarinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider wirkung
DE68916592T2 (de)	1988-06-23	1994-12-01	Agfa Gevaert Nv	Für elektrophotographische Zwecke geeignetes photoempfindliches Aufzeichnungsmaterial.
GB8820174D0 (en)	1988-08-25	1988-09-28	Wellcome Found	Quinoline compound
US5108486A (en) *	1990-02-09	1992-04-28	Kanagawa Chemical Laboratory, Ltd.	Herbicidal substituted-phenyl-1,2,4-triazol-5(1H)-thiones and -ones
US5091528A (en)	1990-09-12	1992-02-25	Allergan, Inc.	6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
DE4036779A1 (de)	1990-11-17	1992-05-21	Basf Ag	Verwendung von arylpolyencarbonsaeuren und ihren derivaten als lichtschutzmittel in kosmetischen zubereitungen
US5147844A (en)	1991-06-14	1992-09-15	Eastman Kodak Company	Mixture on cyan and yellow dyes to form a green hue for color filter array element
FR2683818B1 (fr) *	1991-11-14	1993-12-31	Adir Cie	Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CA2133587C (en)	1992-04-22	2008-11-18	Marcus F. Boehm	Compounds having selectivity for retinoid x receptors
CA2093577C (en)	1992-05-07	2006-01-03	Michael Klaus	Alkyl or alkoxy substituted s-heterocyclic retinoids
CA2107150C (fr)	1992-09-29	2001-10-23	Jean-Daniel Brion	Nouveaux derives chromeniques a chaine laterale trienique, leur procede de preparation et les compositions pharmaceutiques les renfermant
JPH08506323A (ja)	1992-11-25	1996-07-09	ラホヤキャンサーリサーチファウンデーション	Ｒｘｒホモダイマー形成ならびに架橋二環式芳香族化合物および調節遺伝子発現におけるそれらの使用
EP0678086B1 (en)	1993-01-11	1999-12-08	Ligand Pharmaceuticals, Inc.	Compounds having selectivity for retinoid x receptors
WO1994015901A1 (en)	1993-01-11	1994-07-21	Ligand Pharmaceuticals Inc.	Compounds having selectivity for retinoid x receptors
US5455265A (en)	1993-02-11	1995-10-03	Allergan, Inc.	Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5399586A (en)	1993-03-11	1995-03-21	Allergan, Inc.	Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity
US5677336A (en) *	1993-10-21	1997-10-14	Ligand Pharmaceuticals Incorporated	Non-steroid androgen receptor antagonist compounds and methods
EP0749426A1 (en)	1994-03-08	1996-12-27	Takeda Chemical Industries, Ltd.	Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis
FR2719041B1 (fr)	1994-04-26	1996-05-31	Cird Galderma	Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DE69510203T2 (de)	1994-08-10	1999-12-23	F. Hoffmann-La Roche Ag, Basel	Retinoesäure x-rezeptor liganden
US5977125A (en)	1994-10-31	1999-11-02	Eisai Co., Ltd.	Mono-or polyenic carboxylic acid derivatives
US5968908A (en)	1994-12-19	1999-10-19	American Cyanamid Company	Restricted 9-cis retinoids
IL116259A (en)	1994-12-19	2000-07-16	American Cyanamid Co	Analogs of 9-cis retinoic acid and their use
US5696127A (en)	1994-12-22	1997-12-09	Ligand Pharmaceuticals Incorporated	Steroid receptor modulator compounds and methods
US6696459B1 (en) *	1994-12-22	2004-02-24	Ligand Pharmaceuticals Inc.	Steroid receptor modulator compounds and methods
PT800519E (pt)	1994-12-22	2004-03-31	Ligand Pharm Inc	Compostos moduladores de receptores de esteroides e metodos
US5721103A (en)	1994-12-30	1998-02-24	Ligand Pharmaceuticals Incorporated	Trienoic retinoid compounds and methods
PT800503E (pt)	1994-12-30	2000-11-30	Ligand Pharm Inc	Novos compostos retinoides trienoicos e metodos
DK1251125T3 (da) *	1995-06-21	2006-04-18	Sod Conseils Rech Applic	Hidtil ukendte camptothecin-analoger, fremgangsmåde til fremstilling heraf, anvendelse heraf som lægemidler og farmaceutiske præparater indeholdende disse
JP3964478B2 (ja)	1995-06-30	2007-08-22	エーザイ・アール・アンド・ディー・マネジメント株式会社	ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
JPH11511156A (ja) *	1995-08-11	1999-09-28	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	ビフェニル（チオ）アミドおよびビフェニルエタン（チオ）オン誘導体、その製造方法ならびに５−ｈｔ▲下１ｄ▼ 受容体拮抗薬としてのその使用
US5776699A (en)	1995-09-01	1998-07-07	Allergan, Inc.	Method of identifying negative hormone and/or antagonist activities
JP2002515025A (ja)	1995-10-06	2002-05-21	リガンド・ファーマシューティカルズ・インコーポレイテッド	ダイマー選択的ｒｘｒモジュレーターおよびその使用方法
JP2000513362A (ja) *	1996-06-27	2000-10-10	リガンド・ファーマスーティカルス・インコーポレーテッド	アンドロゲン受容体モジュレーター化合物及び方法
US6017924A (en) *	1996-06-27	2000-01-25	Ligand Pharmaceuticals Incorporated	Androgen receptor modulator compounds and methods
FR2752837B1 (fr)	1996-09-02	1999-11-12	Cird Galderma	Nouveaux composes modulateurs des recepteurs hormonaux, les compositions les comprenant et leur utilisation en therapie
WO1999024024A2 (en)	1997-11-12	1999-05-20	F. Hoffmann-La Roche Ag	Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
US6001846A (en) *	1998-02-17	1999-12-14	Ligand Pharmaceuticals Incorporated	Process for the preparation of 1,2-dihydroquinolines
JPH11242304A (ja) *	1998-02-26	1999-09-07	Konica Corp	熱現像感光材料
EP1056775B1 (en)	1998-02-27	2010-04-28	Novo Nordisk A/S	Glp-1 derivatives of glp-1 and exendin with protracted profile of action
JP2002514616A (ja)	1998-05-11	2002-05-21	ノボノルディスクアクティーゼルスカブ	新規化合物、その製造及び使用
US6093826A (en) *	1998-06-08	2000-07-25	Ligand Pharmaceuticals Incorporated	Process for the preparation of C(5)-substituted 1,2-dihydro-5H-chromeno[3,4-f] quinolines
US6147224A (en)	1998-10-01	2000-11-14	Allergan Sales, Inc.	2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
ES2221371T3 (es)	1999-03-08	2004-12-16	Basilea Pharmaceutica Ag	Antagonistas retinoides y el uso de los mismos.
AT407876B (de)	1999-04-30	2001-07-25	Georg Dr Uray	Lumineszierende 4-trifluormethyl-2-chinolinone mit langwelliger uv-absorption und ihre verwendung
US6566372B1 (en) *	1999-08-27	2003-05-20	Ligand Pharmaceuticals Incorporated	Bicyclic androgen and progesterone receptor modulator compounds and methods
CN1391576A (zh) *	1999-08-27	2003-01-15	利甘德药品公司	雄激素受体调节剂化合物及方法
JP2003508397A (ja) *	1999-08-27	2003-03-04	リガンド・ファーマシューティカルズ・インコーポレイテッド	アンドロゲンレセプターモジュレーターとしての８−置換−６−トリフルオロメチル−９−ピリド［３，２−ｇ］キノリン化合物
US6172241B1 (en) *	1999-10-15	2001-01-09	Ligand Pharmaceuticals Incorporated	Process for the preparation of 1,2-dihydroquinolines
US7214690B2 (en) *	2001-02-23	2007-05-08	Ligand Pharmaceuticals Incorporated	Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
US7026484B2 (en) *	2001-02-23	2006-04-11	Ligand Pharmaceuticals Incorporated	Tricyclic androgen receptor modulator compounds and methods
WO2003011824A1 (en) *	2001-07-31	2003-02-13	Bristol-Myers Squibb Company	Bicyclic modulators of androgen receptor function

2000
- 2000-08-25 CN CN00814951A patent/CN1391576A/zh active Pending
- 2000-08-25 BR BR0013597-6A patent/BR0013597A/pt not_active Application Discontinuation
- 2000-08-25 SK SK273-2002A patent/SK2732002A3/sk unknown
- 2000-08-25 MX MXPA02002032A patent/MXPA02002032A/es active IP Right Grant
- 2000-08-25 EP EP00957854A patent/EP1212330B1/en not_active Expired - Lifetime
- 2000-08-25 WO PCT/US2000/023520 patent/WO2001016139A1/en active IP Right Grant
- 2000-08-25 IL IL14804500A patent/IL148045A0/xx unknown
- 2000-08-25 TR TR2002/00507T patent/TR200200507T2/xx unknown
- 2000-08-25 AU AU69414/00A patent/AU778655B2/en not_active Ceased
- 2000-08-25 CA CA002383077A patent/CA2383077A1/en not_active Abandoned
- 2000-08-25 PL PL00353792A patent/PL353792A1/xx not_active Application Discontinuation
- 2000-08-25 JP JP2001519705A patent/JP2003508402A/ja active Pending
- 2000-08-25 DE DE60027443T patent/DE60027443D1/de not_active Expired - Lifetime
- 2000-08-25 US US09/648,684 patent/US6462038B1/en not_active Expired - Lifetime
- 2000-08-25 AT AT00957854T patent/ATE323709T1/de not_active IP Right Cessation
- 2000-08-25 HU HU0202814A patent/HUP0202814A3/hu unknown
- 2000-08-25 KR KR1020027002613A patent/KR20020038741A/ko not_active Application Discontinuation
- 2000-08-25 CZ CZ2002711A patent/CZ2002711A3/cs unknown
2002
- 2002-02-06 ZA ZA200201056A patent/ZA200201056B/xx unknown
- 2002-02-25 NO NO20020913A patent/NO20020913L/no unknown
- 2002-03-25 BG BG106550A patent/BG106550A/xx unknown
- 2002-09-09 US US10/238,363 patent/US20030186970A1/en not_active Abandoned
2006
- 2006-01-25 US US11/340,282 patent/US20070167445A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA200201056B (en)	2003-07-30
DE60027443D1 (de)	2006-05-24
CZ2002711A3 (cs)	2003-11-12
AU6941400A (en)	2001-03-26
SK2732002A3 (en)	2002-07-02
MXPA02002032A (es)	2003-05-19
US20070167445A1 (en)	2007-07-19
AU778655B2 (en)	2004-12-16
BR0013597A (pt)	2002-07-16
WO2001016139A9 (en)	2002-09-19
TR200200507T2 (tr)	2002-10-21
US6462038B1 (en)	2002-10-08
JP2003508402A (ja)	2003-03-04
CA2383077A1 (en)	2001-03-08
HUP0202814A3 (en)	2003-11-28
EP1212330B1 (en)	2006-04-19
CN1391576A (zh)	2003-01-15
PL353792A1 (en)	2003-12-01
EP1212330A1 (en)	2002-06-12
HUP0202814A2 (hu)	2002-12-28
ATE323709T1 (de)	2006-05-15
IL148045A0 (en)	2002-09-12
BG106550A (en)	2002-10-31
KR20020038741A (ko)	2002-05-23
WO2001016139A1 (en)	2001-03-08
NO20020913L (no)	2002-04-29
US20030186970A1 (en)	2003-10-02

Publication	Publication Date	Title
NO20020913D0 (no)	2002-02-25	Androgenreseptor-modulatorforbindelser og fremgangsmåter
NO986100D0 (no)	1998-12-23	Androgene reseptormodulerende forbindelser og fremgangsmÕter
AU2003228283A1 (en)	2003-09-22	Quinazolinone modulators of nuclear receptors
BR9510486A (pt)	1998-06-02	Compostos moduladores de receptores de esteróide e métodos
BG106539A (en)	2002-10-31	Bicyclic androgen and progesterone receptor modulator compounds and methods
CR6478A (es)	2004-02-02	Moduladores del receptor glucocorticoide
AU2002367060A1 (en)	2003-07-30	Heterocyclic modulators of nuclear receptors
YU7797A (sh)	2000-10-30	Kombinovana terapija za osteoporozu
HN1998000157A (es)	1999-06-02	Agonistas de prostaglandinas
DE69531403D1 (de)	2003-09-04	Allosterische modulatoren des nmda-rezeptors
WO2000066590A3 (en)	2001-02-08	Tetracyclic progesterone receptor modulator compounds and methods
BR0104836A (pt)	2002-10-15	Processo para a preparação de moduladores de receptores de glucocorticóides não-esteroidais
WO2002066475A3 (en)	2003-01-23	Tricyclic androgen receptor modulator compounds
DE60233111D1 (de)	2009-09-10	Glucocorticoid-rezeptoren-modulatoren
BR0011741A (pt)	2002-03-19	Compostos de organossilila tendo atividade de modulação do receptor de hormÈnio nuclear
ATE375985T1 (de)	2007-11-15	Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
WO2005009104A3 (en)	2005-12-29	Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
DE69916932T2 (de)	2005-04-21	Kombinationstherapeutika, enthaltend einen selektiven Östrogenrezeptormodulator und Prostaglandin E2
ATE408144T1 (de)	2008-09-15	Assays
MX9301870A (es)	1994-05-31	Antagonistas receptores de angiotensina ii
ECSP993230A (es)	2000-06-19	Antagonistas iii del receptor ccr-3